Li-Ping Su
Overview
Explore the profile of Li-Ping Su including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
691
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei J, Wang L, Zhao Z, Su L
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2024 Oct;
32(5):1407-1413.
PMID: 39479824
Objective: To explore the clinical characteristics and prognosis of patients with diffuse large B-cell lymphoma (DLBCL) of the breast. Methods: The clinical data of 28 DLBCL patients admitted to Shanxi...
2.
Zhang L, Liu Q, Zhou H, Zhang H, Dong Y, Wang X, et al.
Blood Adv
. 2024 Sep;
8(21):5598-5602.
PMID: 39293084
According to the diagnostic criteria for human herpesvirus 8 (HHV-8)-negative/idiopathic multicentric Castleman disease (iMCD) proposed by Castleman Disease Collaborative Network in 2017, there is a group of HHV-8-negative patients with...
3.
Wang W, Zhang W, Su L, Liu L, Gao Y, Wang Q, et al.
Ann Hematol
. 2024 May;
103(8):3061-3069.
PMID: 38805037
In this prospective, multicenter, Phase 2 clinical trial (NCT02987244), patients with peripheral T-cell lymphomas (PTCLs) who had responded to first-line chemotherapy with cyclophosphamide, doxorubicin or epirubicin, vincristine or vindesine, etoposide,...
4.
Miao N, Wang Z, Zhang N, Ma Z, Su L, Zhai Y, et al.
Int J Clin Exp Pathol
. 2024 Feb;
17(1):27-28.
PMID: 38322174
[This corrects the article on p. 138 in vol. 16, PMID: 37559682.].
5.
Jian Y, Chang L, Shi M, Sun Y, Chu X, Xue H, et al.
Blood Adv
. 2023 Nov;
7(24):7581-7584.
PMID: 37922425
No abstract available.
6.
Li X, Guan T, Zhao Z, Liu X, Wang H, Su L, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2023 Oct;
31(5):1366-1371.
PMID: 37846686
Objective: To investigate the clinical characteristics of diffuse large B-cell lymphoma(DLBCL) patients with bone marrow involvement and chromosome abnormalities, and further analyze the correlation between the degree of chromosome abnormality...
7.
An Z, Wu Y, Hou Y, Mei H, Nong W, Li W, et al.
Sci Bull (Beijing)
. 2023 Aug;
68(18):2106-2114.
PMID: 37599175
Rare but critical bleeding events in primary immune thrombocytopenia (ITP) present life-threatening complications in patients with ITP, which severely affect their prognosis, quality of life, and treatment decisions. Although several...
8.
Miao N, Wang Z, Zhang N, Ma Z, Su L, Zhai Y, et al.
Int J Clin Exp Pathol
. 2023 Aug;
16(7):138-149.
PMID: 37559682
Objective: Whether there is a correlation between zinc-finger E-box-binding homolog 1 (ZEB1) and Yes-associated protein 1 (YAP1) with clinical outcome in gliomas remains unclear. Hence, this study aimed to investigate...
9.
Zhang L, Dong Y, Peng H, Li H, Zhang M, Wang H, et al.
Lancet Reg Health West Pac
. 2023 Jun;
34:100720.
PMID: 37283978
Background: Castleman disease (CD) is a group of rare and heterogenous lymphoproliferative disorders including unicentric CD (UCD), human herpesvirus-8(HHV-8)-associated multicentric CD (HHV8-MCD), and HHV-8-negative/idiopathic multicentric CD (iMCD). Knowledge of CD...
10.
Ma J, Yao C, Jia Z, Wang A, Miao X, Gao X, et al.
Allergol Immunopathol (Madr)
. 2023 Jan;
51(1):159-167.
PMID: 36617836
Introduction: Inflammatory bowel disease (IBD), which mainly leads to diarrhea, fatigue, stool blood, abdominal pain, and cramping, is threatening public health. Tripartite motif-containing 52 (TRIM52) has been reported to play...